Antiglioma effects of N6-isopentenyladenosine, an endogenous isoprenoid end product, through the downregulation of epidermal growth factor receptor-Reference-Cited by-同舟云学术

Antiglioma effects of N6-isopentenyladenosine, an endogenous isoprenoid end product, through the downregulation of epidermal growth factor receptor

Published:2016-11-16 Issue:4 Volume:140 Page:959-972
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Ciaglia Elena¹,Abate Mario¹,Laezza Chiara²³,Pisanti Simona¹,Vitale Mario¹,Seneca Vincenzo⁴,Torelli Giovanni⁵,Franceschelli Silvia⁶,Catapano Giuseppe⁴,Gazzerro Patrizia⁶,Bifulco Maurizio¹

Affiliation:

1. Department of Medicine, Surgery and Dentistry “Scuola Medica Salernitana”; University of Salerno; Salerno Italy

2. Institute of Endocrinology and Experimental Oncology; IEOS CNR, Naples Italy

3. Department of Biology and Cellular and Molecular Pathology; University of Naples Federico II; Naples Italy

4. Department of Neurosurgery; “G.Rummo” Medical Hospital; Benevento Italy

5. Department of Neurosurgery, “San Giovanni di Dio e Ruggi d'Aragona University Hospital”; Salerno's School of Medicine; Salerno Italy

6. Department of Pharmacy; University of Salerno; Salerno Italy

Funder

Associazione Italiana per la Ricerca sul Cancro

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference50 articles.

1. The WHO classification of tumors of the nervous system;Kleihues;J Neuropathol Exp Neurol,2002

2. Glioblastoma in adults;Brandes;Crit Rev Oncol Hematol,2008

3. EGF receptor;Wells;Int J Biochem Cell Biol,1999

4. The EGFRvIII variant in glioblastoma multiforme;Gan;J Clin Neurosci,2009

5. A mutant epidermal growth factor receptor common in human glioma confers enhanced tumorigenicity;Nishikawa;Proc Natl Acad Sci USA,1994

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. tRNA modifications and tRNA-derived small RNAs: new insights of tRNA in human disease;Cell Biology and Toxicology;2024-09-14

2. N6‐isopentenyladenosine inhibits aerobic glycolysis in glioblastoma cells by targeting PKM2 expression and activity;FEBS Open Bio;2024-03-21

3. N6-Isopentenyladenosine Impairs Mitochondrial Metabolism through Inhibition of EGFR Translocation on Mitochondria in Glioblastoma Cells;Cancers;2022-12-08

4. Modified Adenosines Sensitize Glioblastoma Cells to Temozolomide by Affecting DNA Methyltransferases;Frontiers in Pharmacology;2022-04-26

5. Extracellular N⁶-isopentenyladenosine (i⁶A) addition induces cotranscriptional i⁶A incorporation into ribosomal RNAs;RNA;2022-04-12